Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea flag South Korea · Delayed Price · Currency is KRW
300,500
-5,500 (-1.80%)
At close: May 28, 2025, 3:30 PM KST

Hanmi Pharm. Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Other Revenue
-0---0--0
Upgrade
Revenue
1,482,7651,495,5021,490,8871,331,5471,203,1861,075,854
Upgrade
Revenue Growth (YoY)
-3.30%0.31%11.97%10.67%11.83%-3.39%
Upgrade
Cost of Revenue
678,623678,465661,638612,994570,433494,935
Upgrade
Gross Profit
804,142817,037829,249718,553632,752580,918
Upgrade
Selling, General & Admin
422,348421,960426,789406,146361,309319,555
Upgrade
Research & Development
183,234178,891181,769154,317146,027212,387
Upgrade
Operating Expenses
609,257604,526604,364564,657507,336531,942
Upgrade
Operating Income
194,885212,511224,885153,896125,41648,976
Upgrade
Interest Expense
-22,932-24,374-28,508-22,647-16,577-24,867
Upgrade
Interest & Investment Income
5,9365,6664,6187,8565,7224,380
Upgrade
Earnings From Equity Investments
-3.65-9.21,258-8,537-4.02-
Upgrade
Currency Exchange Gain (Loss)
5,7859,3181,039-2,64113.073,461
Upgrade
Other Non Operating Income (Expenses)
-31,748-29,309-4,571-3,620-9,277-5,462
Upgrade
EBT Excluding Unusual Items
151,923173,802198,721124,308105,29326,488
Upgrade
Gain (Loss) on Sale of Investments
-51.57-87.922,63047.09--4,514
Upgrade
Gain (Loss) on Sale of Assets
85.5427.741,769451.65-1,062-313.72
Upgrade
Asset Writedown
-2,501-2,488-9,153-3,794-535.2470.68
Upgrade
Pretax Income
149,455171,254193,967121,013103,69722,130
Upgrade
Income Tax Expense
27,56630,82328,60119,45422,2184,841
Upgrade
Earnings From Continuing Operations
121,889140,431165,366101,55881,47817,290
Upgrade
Minority Interest in Earnings
-12,970-19,116-19,135-18,766-14,453-5,330
Upgrade
Net Income
108,919121,315146,23182,79267,02511,959
Upgrade
Net Income to Common
108,919121,315146,23182,79267,02511,959
Upgrade
Net Income Growth
-31.10%-17.04%76.63%23.52%460.45%-77.05%
Upgrade
Shares Outstanding (Basic)
131313131313
Upgrade
Shares Outstanding (Diluted)
131313131313
Upgrade
Shares Change (YoY)
-0.07%-0.08%-0.09%-0.12%-0.11%-0.09%
Upgrade
EPS (Basic)
8589.659566.8311522.126517.335269.87939.25
Upgrade
EPS (Diluted)
8589.659566.8311522.126517.335269.87939.25
Upgrade
EPS Growth
-31.06%-16.97%76.79%23.67%461.07%-77.03%
Upgrade
Free Cash Flow
111,174154,226189,186131,890181,974109,719
Upgrade
Free Cash Flow Per Share
8767.4912162.1314906.6710382.3714307.738617.07
Upgrade
Dividend Per Share
1250.0001250.000----
Upgrade
Gross Margin
54.23%54.63%55.62%53.96%52.59%54.00%
Upgrade
Operating Margin
13.14%14.21%15.08%11.56%10.42%4.55%
Upgrade
Profit Margin
7.35%8.11%9.81%6.22%5.57%1.11%
Upgrade
Free Cash Flow Margin
7.50%10.31%12.69%9.90%15.12%10.20%
Upgrade
EBITDA
292,494309,842323,339250,738214,502110,315
Upgrade
EBITDA Margin
19.73%20.72%21.69%18.83%17.83%10.25%
Upgrade
D&A For EBITDA
97,60997,33198,45496,84289,08661,339
Upgrade
EBIT
194,885212,511224,885153,896125,41648,976
Upgrade
EBIT Margin
13.14%14.21%15.08%11.56%10.42%4.55%
Upgrade
Effective Tax Rate
18.45%18.00%14.74%16.08%21.43%21.87%
Upgrade
Advertising Expenses
-78,78976,03472,62762,20158,772
Upgrade
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.